Hep C Reinfection Prevention Resources

In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations.

Help us launch the Hep Free NYC LGBTQ Initiative by completing a short survey here. This survey allows hepatitis and LGBTQ organizations give advice and recommendations on how we can create an impactful and successful initiative.

The O’Neill Institute for National and Global Health Law, a part of the Georgetown Law, announces the launch of the Hepatitis Policy Project (HPP) to focus on issues and barriers of access to effective treatments for hepatitis C.

The draft clinical criteria for the use of Hep C medication Sofosbuvir (Sovaldi) was presented to the NYS Department Of Health Drug Utilization Review Board (DURB) on Thursday, September 18, 2014.